Cargando…

IDH1 Non-Canonical Mutations and Survival in Patients with Glioma

Background: Non-canonical mutations of the isocitrate dehydrogenase (IDH) genes have been described in about 20–25% and 5–12% of patients with WHO grade II and III gliomas, respectively. To date, the prognostic value of these rare mutations is still a topic of debate. Methods: We selected patients w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Franceschi, Enrico, De Biase, Dario, Di Nunno, Vincenzo, Pession, Annalisa, Tosoni, Alicia, Gatto, Lidia, Tallini, Giovanni, Visani, Michela, Lodi, Raffaele, Bartolini, Stefania, Brandes, Alba Ariela
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7922632/ https://www.ncbi.nlm.nih.gov/pubmed/33669525 http://dx.doi.org/10.3390/diagnostics11020342

Ejemplares similares

Tumor-Associated Microenvironment of Adult Gliomas: A Review
por: Di Nunno, Vincenzo, et al.
Publicado: (2022)

Prevalence of the single-nucleotide polymorphism rs11554137 (IDH1(105GGT)) in brain tumors of a cohort of Italian patients
por: Acquaviva, Giorgia, et al.
Publicado: (2018)

Glioblastoma: Emerging Treatments and Novel Trial Designs
por: Di Nunno, Vincenzo, et al.
Publicado: (2021)

Beyond Imaging and Genetic Signature in Glioblastoma: Radiogenomic Holistic Approach in Neuro-Oncology
por: Gatto, Lidia, et al.
Publicado: (2022)

Discovering the Molecular Landscape of Meningioma: The Struggle to Find New Therapeutic Targets
por: Maggio, Ilaria, et al.
Publicado: (2021)

Molecular Targeted Therapies: Time for a Paradigm Shift in Medulloblastoma Treatment?
por: Gatto, Lidia, et al.
Publicado: (2022)

Glioblastoma Microenvironment: From an Inviolable Defense to a Therapeutic Chance
por: Di Nunno, Vincenzo, et al.
Publicado: (2022)

Distinct MRI pattern of “pseudoresponse” in recurrent glioblastoma multiforme treated with regorafenib: Case report and literature review
por: Gatto, Lidia, et al.
Publicado: (2021)

Meningioma: not always a benign tumor. A review of advances in the treatment of meningiomas
por: Maggio, Ilaria, et al.
Publicado: (2021)

Implications of BRAF V600E mutation in gliomas: Molecular considerations, prognostic value and treatment evolution
por: Di Nunno, Vincenzo, et al.
Publicado: (2023)

Promoter methylation analysis of O6-methylguanine-DNA methyltransferase in glioblastoma: detection by locked nucleic acid based quantitative PCR using an imprinted gene (SNURF) as a reference
por: Morandi, Luca, et al.
Publicado: (2010)

Tumor Microenvironment in Gliomas: A Treatment Hurdle or an Opportunity to Grab?
por: Di Nunno, Vincenzo, et al.
Publicado: (2023)

miR-196B-5P and miR-200B-3P Are Differentially Expressed in Medulloblastomas of Adults and Children
por: Visani, Michela, et al.
Publicado: (2020)

Correction: Visani et al. miR-196B-5P and miR-200B-3P Are Differentially Expressed in Medulloblastomas of Adults and Children. Diagnostics 2020, 10, 265
por: Visani, Michela, et al.
Publicado: (2021)

Potential protective and therapeutic role of immune checkpoint inhibitors against viral infections and COVID-19
por: Gatto, Lidia, et al.
Publicado: (2020)

DCVax-L Vaccination in Patients with Glioblastoma: Real Promise or Negative Trial? The Debate Is Open
por: Gatto, Lidia, et al.
Publicado: (2023)

CAR-T cells neurotoxicity from consolidated practice in hematological malignancies to fledgling experience in CNS tumors: fill the gap
por: Gatto, Lidia, et al.
Publicado: (2023)

Olfactory neuroblastoma: diagnosis, management, and current treatment options
por: Tosoni, Alicia, et al.
Publicado: (2023)

Molecular alterations in pancreatic tumors
por: Visani, Michela, et al.
Publicado: (2021)

The percentage of Epidermal Growth Factor Receptor (EGFR)-mutated neoplastic cells correlates to response to tyrosine kinase inhibitors in lung adenocarcinoma
por: de Biase, Dario, et al.
Publicado: (2017)

Allele Specific Locked Nucleic Acid Quantitative PCR (ASLNAqPCR): An Accurate and Cost-Effective Assay to Diagnose and Quantify KRAS and BRAF Mutation
por: Morandi, Luca, et al.
Publicado: (2012)

Role of microRNAs in the main molecular pathways of hepatocellular carcinoma
por: Vasuri, Francesco, et al.
Publicado: (2018)

Next-Generation Sequencing of Lung Cancer EGFR Exons 18-21 Allows Effective Molecular Diagnosis of Small Routine Samples (Cytology and Biopsy)
por: de Biase, Dario, et al.
Publicado: (2013)

Molecular Diagnostic of Solid Tumor Using a Next Generation Sequencing Custom-Designed Multi-Gene Panel
por: de Biase, Dario, et al.
Publicado: (2020)

Definition of miRNAs Expression Profile in Glioblastoma Samples: The Relevance of Non-Neoplastic Brain Reference
por: Visani, Michela, et al.
Publicado: (2013)

Gefitinib in patients with progressive high-grade gliomas: a multicentre phase II study by Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO)
por: Franceschi, E, et al.
Publicado: (2007)

Not the same thing: metastatic PTCs have a different background than ATCs
por: de Biase, Dario, et al.
Publicado: (2018)

Next Generation Sequencing Improves the Accuracy of KRAS Mutation Analysis in Endoscopic Ultrasound Fine Needle Aspiration Pancreatic Lesions
por: de Biase, Dario, et al.
Publicado: (2014)

miRNAs Expression Analysis in Paired Fresh/Frozen and Dissected Formalin Fixed and Paraffin Embedded Glioblastoma Using Real-Time PCR
por: de Biase, Dario, et al.
Publicado: (2012)

Adjuvant chemotherapy in average-risk adult medulloblastoma patients improves survival: a long term study
por: Franceschi, E., et al.
Publicado: (2020)

Therapies for IDH-Mutant Gliomas
por: Alshiekh Nasany, Ruham, et al.
Publicado: (2023)

Early tumour shrinkage as a survival predictor in patients with recurrent glioblastoma treated with bevacizumab in the AVAREG randomized phase II study
por: Brandes, Alba A., et al.
Publicado: (2017)

Mutant BRAF in low-grade epilepsy-associated tumors and focal cortical dysplasia
por: Marucci, Gianluca, et al.
Publicado: (2014)

Correlation of molecular alterations with pathological features in hepatocellular carcinoma: Literature review and experience of an Italian center
por: Maloberti, Thais, et al.
Publicado: (2022)

Sex-specific clinicopathological significance of novel (Frizzled-7) and established (MGMT, IDH1) biomarkers in glioblastoma
por: Schiffgens, Salveena, et al.
Publicado: (2016)

The Risk Assessment in Low-Grade Gliomas: An Analysis of the European Organization for Research and Treatment of Cancer (EORTC) and the Radiation Therapy Oncology Group (RTOG) criteria
por: Lanese, Andrea, et al.
Publicado: (2018)

Postoperative risk of IDH-mutant glioma–associated seizures and their potential management with IDH-mutant inhibitors
por: Drumm, Michael R., et al.
Publicado: (2023)

BRAF Exon 15 Mutations in Papillary Carcinoma and Adjacent Thyroid Parenchyma: A Search for the Early Molecular Events Associated with Tumor Development
por: Acquaviva, Giorgia, et al.
Publicado: (2020)

Induced expression of the Fragaria × ananassa Rapid alkalinization factor‐33‐like gene decreases anthracnose ontogenic resistance of unripe strawberry fruit stages
por: Merino, Maria Cecilia, et al.
Publicado: (2019)

454 next generation-sequencing outperforms allele-specific PCR, Sanger sequencing, and pyrosequencing for routine KRAS mutation analysis of formalin-fixed, paraffin-embedded samples
por: Altimari, Annalisa, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_iq3jv2ep5g99hm7hrmc90btqq9